Sanofi (SNY) is expected to report earnings on Friday, October 23, 2026, after the close. Consensus EPS estimate is $1.71.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-30 | FY2026 Q2 | $1.10 | $1.21 | +10.0% | $14.06B |
| 2026-04-23 | FY2026 Q1 | $1.06 | $1.10 | +3.8% | $12.94B |
| 2026-01-29 | FY2025 Q4 | $0.84 | $0.89 | +6.0% | $14.34B |
| 2025-10-24 | FY2025 Q3 | $1.60 | $1.70 | +6.2% | $15.43B |
| 2025-07-31 | FY2025 Q2 | $0.96 | $0.90 | -6.2% | $12.64B |
| 2025-04-24 | FY2025 Q1 | $0.90 | $1.02 | +13.3% | $11.63B |
| 2025-01-30 | FY2024 Q4 | $0.71 | $0.70 | -1.4% | $7.90B |
| 2024-10-25 | FY2024 Q3 | $1.35 | $1.57 | +16.3% | $15.53B |
SNY has beaten consensus EPS in 6 of its last 8 reported quarters.
See SNY on the live calendar →